Kiniksa Pharmaceuticals Tech Stack

Biopharmaceutical company focused on cardiovascular therapies with unmet need

Biotechnology Research Lexington, Massachusetts 201–500 employees Founded 2015 Public Company

Kiniksa is a public biopharmaceutical company developing therapies for cardiovascular diseases. Their tech stack—Veeva Vault, SAP S/4HANA, Salesforce, Azure, AWS—reflects a compliance-heavy, regulated-industry footprint typical of drug commercialization. Sales hiring (28 roles) dwarfs R&D (3 research, 3 product), signaling a company in mid-to-late-stage product launch phase rather than discovery-focused pipeline expansion. Active projects centered on rilonacept launch, patient access programs, and provider education align with documented pain points around clinical trial enrollment and healthcare provider awareness.

Tech Stack 12 technologies

Core StackAWS SAP S/4HANA Tableau Veeva Vault SharePoint Microsoft Office Azure IAM Drupal Salesforce Marketing Cloud Veeva PromoMats Excel

What Kiniksa Pharmaceuticals Is Building

◆Challenges

Launching new drug
Reducing clinical trial costs
Ensuring timely patient access
Compliance with oig guidance
Patient enrollment challenges
Educating healthcare providers
Unmet data needs
Ensuring compliance with laws and regulations
Protecting information assets from threats
Timely delivery of documents

▲Active Projects

Kiniksa one connect patient services education
Strategic territory plan
Opportunity facilitation
Launch of rilonacept in recurrent pericarditis
Hospital exhibit opportunities
Facilitate short-term and future opportunities aligned with kiniksa’s mission
Facilitate short-term and future opportunities through virtual and in-person engagements
Patient services program
Patient support program
Digital/omnichannel transformation

Hiring Activity

Steady65 roles · 30 in 30d

Department

Sales

Marketing

Healthcare

Ops

Product

Research

Manufacturing

Security

Seniority

Senior

Director

Manager

Mid

Junior

Notable leadership hires: Regional Sales Director, Patient Access Lead, Sales Director

Company intelligence

Find more companies like Kiniksa Pharmaceuticals by tech stack, pain points and active projects

Get started free

About Kiniksa Pharmaceuticals

Kiniksa discovers, develops, and commercializes biologic therapies targeting unmet needs in cardiovascular disease. Founded in 2015 and publicly traded, the company operates with approximately 201–500 employees across discovery, development, and commercial functions. Kiniksa's approach emphasizes validated biological mechanisms and differentiated clinical rationale. The organization operates globally, with hiring activity in the United States and Switzerland, and spans functions from manufacturing and research through sales, marketing, patient services, and regulatory operations.

HeadquartersLexington, Massachusetts

Company Size201–500 employees

Founded2015

Hiring MarketsUnited States, Switzerland

Frequently Asked Questions

What is Kiniksa's tech stack?

Kiniksa uses Veeva Vault and Veeva PromoMats for regulatory and promotional content, SAP S/4HANA for enterprise operations, Salesforce Marketing Cloud for marketing, Azure and AWS for cloud infrastructure, and Tableau for analytics. This stack is typical of regulated pharmaceutical organizations managing compliance, supply chain, and commercial workflows.

Is Kiniksa hiring sales roles?

Yes. Sales represents the largest hiring department with 28 active roles as of the data snapshot, including Regional Sales Director, Sales Director, and Patient Access Lead positions. The company is hiring in the United States and Switzerland.

What is Kiniksa working on?

Current focus includes the launch of rilonacept in recurrent pericarditis, expansion of patient services and support programs, strategic territory planning, provider education, and digital/omnichannel transformation. Key pain points center on clinical trial enrollment, ensuring timely patient access, and educating healthcare providers.